Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01237366 · ClinicalTrials.gov registry record · Phase 1
Study Targeting Affect Regulation
A Phase 1 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT01237366 is a Phase 1 study that has completed, run by University of California, San Francisco. The registered enrollment target is 56 participants.
The verdict
NCT01237366, a Phase 1 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
This Phase Ib pilot RCT will examine the safety, feasibility, and acceptability of a multi-component intervention to address traumatic stress symptoms among HIV-positive, methamphetamine-using men who have sex with men (MSM). Following a baseline assessment, 56 participants will be randomized to receive either: 1) a 7-session intervention to address traumatic stress related to living with HIV/AIDS; or 2) a 7-session, attention-control condition. Follow-up assessments will be administered at 1 and 3 months post-randomization.
Interventions
- BEHAVIORAL Resilient Affective Processing Therapy (RAPT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2010-09 |
| Est. Completion | 2014-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01237366
The ClinicalTrials.gov registry entry for NCT01237366 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Resilient Affective Processing Therapy (RAPT) is the first listed.
NCT01237366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01237366 about?
NCT01237366 is a clinical study titled "Study Targeting Affect Regulation". This Phase Ib pilot RCT will examine the safety, feasibility, and acceptability of a multi-component intervention to address traumatic stress symptoms among HIV-positive, methamphetamine-using men who have sex with men (MSM). Following a baseline assessment, 56 participants will be randomized to rec...
What is the current status of trial NCT01237366?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2010-09. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01237366?
The interventions under investigation include: Resilient Affective Processing Therapy (RAPT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01237366?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.